Research Article
The Effect of Gefitinib on Treatment Necessity and Prognosis of NSCLC Patients with Early EGFR Mutations
Table 2
Comparison of recurrence rate between experimental group and control group.
| | Groups | — | No recurrence | Recurrence | | |
| | Control group | — | 26 (59.09) | 18 (40.91) | 5.937 | 0.015 | | Experimental group | — | 17 (34.00) | 33 (66.00) | | Experimental group | Not taking medication | 6 (19.35) | 25 (80.65) | 7.797 | 0.005 | | Taking medication | 11 (57.89) | 8 (42.11) |
|
|
